Adma Biologics Inc (ADMA)
$11.41 -2.89% Close Oct 30, 2026 Live
Adma Biologics stock today
Adma Biologics closed at $11.41 on October 30, 2026, down 2.89% on the day. Over the past year it returned -25.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.65 billion.
$10.00$15.00$20.00
NovJan 2026MarMayJulSep
| Period | ADMA | S&P 500 (SPY) |
|---|---|---|
| 1 month | +13.8% | -0.9% |
| 3 months | +31.6% | +2.1% |
| Year to date | -37.4% | +11.7% |
| 1 year | -25.3% | +12.4% |
| 3 years | +245.8% | +88.5% |
| 5 years | +784.5% | +76.0% |
Key statistics
- Market value
- $2.65B
- P/E (trailing)
- 16.3
- Forward P/E
- 13.1
- Price / sales
- 5.2
- 52-week range
- $7.60 to $20.38
- Next report
- Nov 4, 2026
About Adma Biologics
Manufactures and distributes plasma-derived biologics for immunodeficiency, bleeding disorders, and other conditions.
Sector: Health Care
More on Adma Biologics
- Financials: revenue, earnings and segmentsRevenue +20% in the year to Dec 2025
- Valuation: P/E history and peersP/E 16.3
- Returns: what $1,000 became$1,000 ten years ago is $1,944 today
No forecast, no recommendation. This page describes Adma Biologics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.